Clik here to view.
Bristol-Myers to Slash Jobs, Shut Plants
Bristol-Myers Squibb said today it will lay off 10% of its work force—totaling 4,300 jobs—and close or sell half its 27 factories in a plan to save $1.5 billion by 2010, the Wall Street Journal...
View ArticleClik here to view.
SEC Delves Deeper Into Execs' Pay
The SEC wants companies to tell shareholders how they measure an executive’s performance when calculating pay, but companies are balking, reports the Wall Street Journal. Their reticence has prompted...
View ArticleClik here to view.
Bristol-Myers Makes Bid for Icahn's ImClone
Already a 17% shareholder, Bristol-Myers Squibb laid down a $4.5 billion offer to buy the rest of ImClone shares, the Wall Street Journal reports. The $60-a-share offer, sent to ImClone chairman Carl...
View ArticleClik here to view.
Novartis Acquires Plavix Rival
Novartis AG will pay a San Francisco biopharmaceutical company $75 million—with the potential for an additional $500 million—for the worldwide rights to an experimental anticlotting drug the Swiss drug...
View ArticleClik here to view.
Big Pharma Flouts Laws on Off-Label Uses
Back in 2004, a unit of drug giant Pfizer pleaded guilty to marketing a drug, Neurotonin, for unapproved uses, paid $430 million in fines, and promised to clean up its act—which it had no intention of...
View ArticleClik here to view.
Scientists Hail Advances on Melanoma, Lung Cancer
Scientists say they've made notable progress against two of the most difficult cancers to treat—lung cancer and melanoma, reports the New York Times . On lung cancer, a drug in study of 82 people...
View ArticleClik here to view.
Bristol-Myers Allegations: Push Our Drugs, Meet the Lakers!
It's a good day for bribery allegations: In California, Bristol-Meyers Squibb is accused of bribing doctors to push its drugs in exchange for swanky gifts and "happy hours" with Los Angeles Lakers...
View ArticleClik here to view.
Do the Huge Amounts We Spend on Cancer Pay Off?
The US spends a lot more on cancer treatments than most countries, spending an average of $70,000 per case, compared to $44,000 in Europe. But it's worth it, a controversial new study argues, because...
View ArticleClik here to view.
New Drugs May Deliver Potent Cancer Defense
A meeting of the American Society of Clinical Oncology is taking place this weekend in Chicago, and a spate of genuinely hopeful stories is emerging about new drugs and strategies. The Wall Street...
View Article
